TD Cowen maintains Buy on Strive, cuts price target to $28
TD Cowen analyst Lance Vitanza maintained a Buy rating on Strive (NASDAQ: ASST) and lowered the price target from $32 to $28.

*this image is generated using AI for illustrative purposes only.
TD Cowen analyst Lance Vitanza has maintained a Buy rating on Strive (NASDAQ: ASST) while adjusting the valuation outlook. The firm lowered the price target for the stock to $28, down from the previous target of $32.
The revised price target reflects an updated assessment of the company's future performance potential. Despite the reduction, the Buy rating indicates continued confidence in the stock's ability to deliver returns.
Strive is listed on the NASDAQ under the ticker symbol ASST.
What specific factors led TD Cowen to revise Strive's future performance potential?
How might this price target adjustment influence investor sentiment toward ASST in the short term?
What upcoming catalysts could drive Strive's stock toward the new $28 price target?


























